2023
DOI: 10.3390/jof9050513
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic Approach to Coccidioidomycosis in Solid Organ Transplant Recipients

Abstract: Coccidioidomycosis is a fungal infection endemic in the southwestern United States, Mexico, and parts of Central and South America. While coccidioidomycosis is associated with mostly mild infections in the general population, it can lead to devastating infections in immunocompromised patients, including solid organ transplant (SOT) recipients. Early and accurate diagnosis is important in achieving better clinical outcomes in immunocompromised patients. However, the diagnosis of coccidioidomycosis in SOT recipi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…Targets for Coccidioides-specific PCRs include ITS regions [98,99], Antigen 2 and Proline Rich Antigen [100]. Variable sensitivities (74-100%) have been reported on respiratory, fresh and FFPE tissue and CSF samples [101]. The GeneSTAT.MDx Coccidioides (DxNA LLC, St. George, UT, USA) was one FDA-approved PCR, with 100% sensitivity and 93.8-100% specificity; however, it is no longer marketed [102].…”
Section: Endemic Mycosesmentioning
confidence: 99%
“…Targets for Coccidioides-specific PCRs include ITS regions [98,99], Antigen 2 and Proline Rich Antigen [100]. Variable sensitivities (74-100%) have been reported on respiratory, fresh and FFPE tissue and CSF samples [101]. The GeneSTAT.MDx Coccidioides (DxNA LLC, St. George, UT, USA) was one FDA-approved PCR, with 100% sensitivity and 93.8-100% specificity; however, it is no longer marketed [102].…”
Section: Endemic Mycosesmentioning
confidence: 99%